[Evolution of the presence of women in decision-making bodies of the Spanish national health system]. / Evolución de la presencia de mujeres en los órganos de decisión del Sistema Nacional de Salud en España.

OBJECTIVE: To examine the presence of women in the organs of the Interterritorial Council of the Spanish National Health System (CISNS). METHOD: Annual reports of the CISNS from 2005 to 2022 were analyzed. Artificial intelligence was used to assign gender, and percentages of women's participation were calculated. Temporal evolution, vertical segregation, and horizontal segregation were analyzed. RESULTS: Between 2005 and 2022, there were 14,308 participations in 85 organs, with 52% women, rising from 42% in 2005 to 61% in 2022. There was a higher participation of women in propositional organs (54%), followed by executive ones (50%), and plenary sessions (40%). The General State Administration had 61% women compared to 48% in autonomous communities. Women's participation varied by topic, being higher (82%) in gender violence and lower (35%) in inspection. CONCLUSIONS: Although there is a slight reduction in the participation gap between women and men, inequalities persist. Women have less presence in higher hierarchical levels (plenary sessions), maintaining vertical segregation. Additionally, women's representation in certain topics remains low, maintaining horizontal segregation. Concrete actions must be taken to continue advancing equality and improving health outcomes in society as a whole.

Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.

BACKGROUND: With more than 7500 cases reported since April 2022, Spain has experienced the highest incidence of mpox in Europe. From 12 July onward, the modified vaccinia Ankara-Bavaria Nordic (MVA-BN) smallpox vaccine was offered as pre-exposure prophylaxis for those receiving pre-exposure prophylaxis for human immunodeficiency virus (HIV-PrEP). Our aim was to assess the effectiveness of 1 dose of MVA-BN vaccine as pre-exposure prophylaxis against mpox virus (MPXV) infection in persons on HIV-PrEP. METHODS: National retrospective cohort study between 12 July and 12 December 2022. Individuals aged ≥18 years receiving HIV-PrEP as of 12 July with no previous MPXV infection or vaccination were eligible. Each day, we matched individuals receiving a first dose of vaccine and unvaccinated controls of the same age and region. We used a Kaplan-Meier estimator, calculated risk ratios (RR) and vaccine effectiveness (VE = [1 - RR]x100). RESULTS: We included 5660 matched pairs, with a median follow-up of 62 days (interquartile range, 24-97). Mpox cumulative incidence was 5.6 per 1000 (25 cases) in unvaccinated and 3.5 per 1000 (18 cases) in vaccinated. No effect was found during days 0-6 post-vaccination (VE, -38.3; 95% confidence interval [CI], -332.7 to 46.4), but VE was 65% at ≥7 days (95% CI, 22.9 to 88.0) and 79% at ≥14 days (95% CI, 33.3 to 100.0) post-vaccination. CONCLUSIONS: One dose of MVA-BN vaccine offered protection against mpox in most-at-risk population shortly after the vaccination. Further studies need to assess the VE of a second dose and the duration of protection over time.

[Comparación de la vigilancia centinela de infecciones respiratorias agudas frente a la vigilancia universal en La Rioja en la temporada 2021-2022.] / Comparison of sentinel surveillance of acute respiratory infections versus universal surveillance in La Rioja in the 2021-2022 season.

OBJECTIVE: Sentinel surveillance is used to monitor health problems. The COVID detection strategy conducts universal surveillance of SARS-CoV-2 infection, which can be monitored by sentinel systems, through surveillance of mild acute respiratory infection (IRA) or severe respiratory infection (IRAG). The objective of this study was to compare incidence data obtained through sentinel surveillance against versus universal surveillance in acute respiratory infections. METHODS: A descriptive study of the incidences (cases/100,000 inhabitants) of acute respiratory infection (sudden onset of cough, sore throat, dyspnea or runny nose and clinical judgment of infection) was carried out in the entire population of La Rioja recorded in the primary care medical record, and in a sentinel cohort, by age and sex during the period from weeks 40-2021 to 06-2022. For SARI, the total number of hospitalized cases per 100,000 inhabitants with onset of symptoms in the previous ten days was calculated, as well as the incidence in a systematic selection of all SARI hospitalized one day a week. Weekly incidence rates were calculated in each cohort from week forty of 2021 to week six of 2022 by sex and age group. The characteristics of the population were expressed in their distribution by number and percentage. RESULTS: The data observed for ARI were similar in both systems by sex and age, except for the zero to four-year-old group and the group over seventy-nine years of age, where differences were observed, with the highest ARI figures in the first age group in sentinel surveillance, while in the older group they were superior in universal surveillance. SARIs showed a similar incidence, except in the fifteen/fourty-four age groups, which was higher in universal surveillance than in sentinel surveillance. CONCLUSIONS: There are no significant differences. Sentinel surveillance allows optimization of resources, being the most efficient methods for surveillance of high-incidence diseases.

OBJETIVO: La vigilancia centinela se emplea para monitorizar problemas de salud. En la Estrategia de detección de COVID se lleva a cabo vigilancia universal de infección por SARS-CoV-2, que puede pasar a monitorización mediante sistemas centinela, a través de vigilancia de infección respiratoria aguda leve (IRA) o grave (IRAG). El objetivo del presente trabajo fue comparar datos de incidencia obtenidos mediante vigilancia centinela frente a vigilancia universal en las infecciones respiratorias agudas. METODOS: Se realizó un estudio descriptivo de las incidencias (casos por cada 100.000 habitantes) de infección respiratoria aguda (comienzo súbito de tos, dolor de garganta, disnea o rinorrea y juicio clínico de infección) en toda la población de La Rioja, registrados en la historia clínica de Atención Primaria, y en una cohorte centinela, por edad y sexo durante el periodo que incluye la semana 40-2021 hasta la 06-2022. Para IRAG se calcularon los casos hospitalizados totales por cada 100.000 habitantes con inicio de síntomas en los diez días previos, así como la incidencia en una selección sistemática de todos los IRAG hospitalizados un día a la semana. Se calcularon las tasas de incidencia semanales en cada cohorte desde la semana cuarenta del año 2021 a la semana seis del año 2022 por sexo y grupo de edad. Las características de la población se expresaron en su distribución por número y porcentaje. RESULTADOS: Los datos observados para IRA fueron similares en ambos sistemas por sexo y edad, salvo para el grupo de cero a cuatro años y el de más de setenta y nueve años, donde se observaron diferencias, siendo las cifras de IRA más elevadas en el primer grupo de edad en la vigilancia centinela, mientras que en el grupo de mayores fueron superiores en la vigilancia universal. Las IRAG mostraron una incidencia similar, excepto en los grupos de edad de quince a cuarenta y cuatro años, que fue mayor en vigilancia universal que en el centinela. CONCLUSIONES: No se observan diferencias importantes. La vigilancia centinela permite optimización de recursos, siendo los métodos más eficientes para vigilancia de enfermedades de alta incidencia.

Comparación de la vigilancia centinela de infecciones respiratorias agudas frente a la vigilancia universal en La Rioja en la temporada 2021-2022 / Comparison of sentinel surveillance of acute respiratory infections versus universal surveillance in La Rioja in the 2021-2022 season

Fundamentos: La vigilancia centinela se emplea para monitorizar problemas de salud. En laEstrategia de detección de COVID se lleva a cabo vigilancia universal de infección por SARS-CoV-2, que puede pasar a monitorización mediante sistemas centinela, a través de vigilancia de infección respiratoria aguda leve (IRA) o grave (IRAG). El objetivo del presente trabajo fue comparar datos de incidencia obtenidos mediante vigilancia centinela frente a vigilancia universal en las infecciones respiratorias agudas. Métodos: Se realizó un estudio descriptivo de las incidencias (casos por cada 100.000 habitantes) de infección respiratoria aguda (comienzo súbito de tos, dolor de garganta, disnea o rinorrea y juicio clínico de infección) en toda la población de La Rioja, registrados en la historia clínica de Atención Primaria, y en una cohorte centinela, por edad y sexo durante el periodo que incluye la semana 40-2021 hasta la 06-2022. Para IRAG se calcularon los casos hospitalizados totales por cada 100.000 habitantes con inicio de síntomas en los diez días previos, así como la incidencia en una selección sistemática de todos los IRAG hospitalizados un día a la semana. Se calcularon las tasas de incidencia semanales en cada cohorte desde la semana cuarenta del año 2021 a la semana seis del año 2022 por sexo y grupo de edad. Las características de la población se expresaron en su distribución por número y porcentaje. Resultados: Los datos observados para IRA fueron similares en ambos sistemas por sexo y edad, salvo para el grupo de cero a cuatro años y el de más de setenta y nueve años, donde se observaron diferencias, siendo las cifras de IRA más elevadas en el primer grupo de edad en la vigilancia centinela, mientras que en el grupo de mayores fueron superiores en la vigilancia universal. Las IRAG mostraron una incidencia similar, excepto en los grupos de edad de quince a cuarenta y cuatro años, que fue mayor en vigilancia universal que en el centinela.(AU)

Background: Sentinel surveillance is used to monitor health problems. The COVID detection strategy conducts universal surveillance of SARS-CoV-2 infection, which can be monitored by sentinel systems, through surveillance of mild acute respiratory infection (IRA) or severe respiratory infection (IRAG). The objective of this study was to compare incidence data obtained through sentinel surveillance against versus universal surveillance in acute respiratory infections. Methods: A descriptive study of the incidences (cases/100,000 inhabitants) of acute respiratory infection (sudden onset of cough, sore throat, dyspnea or runny nose and clinical judgment of infection) was carried out in the entire population of La Rioja recorded in the primary care medical record, and in a sentinel cohort, by age and sex during the period from weeks 40-2021 to 06-2022. For SARI, the total number of hospitalized cases per 100,000 inhabitants with onset of symptoms in the previous ten days was calculated, as well as the incidence in a systematic selection of all SARI hospitalized one day a week. Weekly incidence rates were calculated in each cohort from week forty of 2021 to week six of 2022 by sex and age group. The characteristics of the population were expressed in their distribution by number and percentage.Results: The data observed for ARI were similar in both systems by sex and age, except for the zero to four-year-old group and the group over seventy-nine years of age, where differences were observed, with the highest ARI figures in the first age group in sentinel surveillance, while in the older group they were superior in universal surveillance. SARIs showed a similar incidence, except in the fifteen/fourty-four age groups, which was higher in universal surveillance than in sentinel surveillance.(AU)

Lifting COVID-19 mitigation measures in Spain (May-June 2020).

Introduction: The state of alarm was declared in Spain due to the COVID-19 epidemic on March 14, 2020, and established population confinement measures. The objective is to describe the process of lifting these mitigation measures. Methods: The Plan for the Transition to a New Normality, approved on April 28, contained four sequential phases with progressive increase in socio-economic activities and population mobility. In parallel, a new strategy for early diagnosis, surveillance and control was implemented. A bilateral decision mechanism was established between the Spanish Government and the autonomous communities (AC), guided by a set of qualitative and quantitative indicators capturing the epidemiological situation and core capacities. The territorial units were established ad-hoc and could be from Basic Health Zones to entire AC. Results: The process run from May 4 to June 21, 2020. AC implemented plans for reinforcement of core capacities. Incidence decreased from a median (50% of territories) of 7.4 per 100,000 in 7 days at the beginning to 2.5 at the end. Median PCR testing increased from 53% to 89% of suspected cases and PCR total capacity from 4.5 to 9.8 per 1000 inhabitants weekly; positivity rate decreased from 3.5% to 1.8%. Median proportion of cases with traced contacts increased from 82% to 100%. Conclusion: Systematic data collection, analysis, and interterritorial dialogue allowed adequate process control. The epidemiological situation improved but, mostly, the process entailed a great reinforcement of core response capacities nation-wide, under common criteria. Maintaining and further reinforcing capacities remained crucial for responding to future waves.

Introducción: El 14 de marzo de 2020 España declaró el estado de alarma por la pandemia por COVID-19 incluyendo medidas de confinamiento. El objetivo es describir el proceso de desescalada de estas medidas. Métodos: Un plan de transición hacia una nueva normalidad, del 28 de abril, incluía 4 fases secuenciales incrementando progresivamente las actividades socioeconómicas y la movilidad. Concomitantemente, se implementó una nueva estrategia de diagnóstico precoz, vigilancia y control. Se estableció un mecanismo de decisión bilateral entre Gobierno central y comunidades autónomas (CCAA), guiado por un panel de indicadores cualitativos y cuantitativos de la situación epidemiológica y las capacidades básicas. Las unidades territoriales evaluadas comprendían desde zonas básicas de salud hasta CCAA. Resultados: El proceso se extendió del 4 de mayo al 21 de junio y se asoció a planes de refuerzo de las capacidades en las CCAA. La incidencia disminuyó de una mediana inicial de 7,4 por 100.000 en 7 días a 2,5 al final del proceso. La mediana de pruebas PCR aumentó del 53% al 89% de los casos sospechosos, y la capacidad total de 4,5 a 9,8 pruebas semanales por 1.000 habitantes; la positividad disminuyó del 3,5% al 1,8%. La mediana de casos con contactos trazados aumentó del 82% al 100%. Conclusión: La recogida y análisis sistemático de información y el diálogo interterritorial logaron un adecuado control del proceso. La situación epidemiológica mejoró, pero sobre todo, se aumentaron las capacidades, en todo el país y con criterios comunes, cuyo mantenimiento y refuerzo fue clave en olas sucesivas.

Lifting COVID-19 mitigation measures in Spain (May-June 2020).

INTRODUCTION: The state of alarm was declared in Spain due to the COVID-19 epidemic on March 14, 2020, and established population confinement measures. The objective is to describe the process of lifting these mitigation measures. METHODS: The Plan for the Transition to a New Normality, approved on April 28, contained four sequential phases with progressive increase in socio-economic activities and population mobility. In parallel, a new strategy for early diagnosis, surveillance and control was implemented. A bilateral decision mechanism was established between the Spanish Government and the autonomous communities (AC), guided by a set of qualitative and quantitative indicators capturing the epidemiological situation and core capacities. The territorial units were established ad-hoc and could be from Basic Health Zones to entire AC. RESULTS: The process run from May 4 to June 21, 2020. AC implemented plans for reinforcement of core capacities. Incidence decreased from a median (50% of territories) of 7.4 per 100,000 in 7 days at the beginning to 2.5 at the end. Median PCR testing increased from 53% to 89% of suspected cases and PCR total capacity from 4.5 to 9.8 per 1000 inhabitants weekly; positivity rate decreased from 3.5% to 1.8%. Median proportion of cases with traced contacts increased from 82% to 100%. CONCLUSION: Systematic data collection, analysis, and interterritorial dialogue allowed adequate process control. The epidemiological situation improved but, mostly, the process entailed a great reinforcement of core response capacities nation-wide, under common criteria. Maintaining and further reinforcing capacities remained crucial for responding to future waves.

Lifting COVID-19 mitigation measures in Spain (May–June 2020 / La desescalada de las medidas de mitigación contra el COVID-19 en España (mayo–junio 2020)

Introduction: The state of alarm was declared in Spain due to the COVID-19 epidemic on March 14, 2020, and established population confinement measures. The objective is to describe the process of lifting these mitigation measures. Methods: The Plan for the Transition to a New Normality, approved on April 28, contained four sequential phases with progressive increase in socio-economic activities and population mobility. In parallel, a new strategy for early diagnosis, surveillance and control was implemented. A bilateral decision mechanism was established between the Spanish Government and the autonomous communities (AC), guided by a set of qualitative and quantitative indicators capturing the epidemiological situation and core capacities. The territorial units were established ad-hoc and could be from Basic Health Zones to entire AC. Results: The process run from May 4 to June 21, 2020. AC implemented plans for reinforcement of core capacities. Incidence decreased from a median (50% of territories) of 7.4 per 100,000 in 7 days at the beginning to 2.5 at the end. Median PCR testing increased from 53% to 89% of suspected cases and PCR total capacity from 4.5 to 9.8 per 1000 inhabitants weekly; positivity rate decreased from 3.5% to 1.8%. Median proportion of cases with traced contacts increased from 82% to 100%. Conclusion: Systematic data collection, analysis, and interterritorial dialogue allowed adequate process control. The epidemiological situation improved but, mostly, the process entailed a great reinforcement of core response capacities nation-wide, under common criteria. Maintaining and further reinforcing capacities remained crucial for responding to future waves.(AU)

Introducción: El 14 de marzo de 2020 España declaró el estado de alarma por la pandemia por COVID-19 incluyendo medidas de confinamiento. El objetivo es describir el proceso de desescalada de estas medidas. Métodos: Un plan de transición hacia una nueva normalidad, del 28 de abril, incluía 4 fases secuenciales incrementando progresivamente las actividades socioeconómicas y la movilidad. Concomitantemente, se implementó una nueva estrategia de diagnóstico precoz, vigilancia y control. Se estableció un mecanismo de decisión bilateral entre Gobierno central y comunidades autónomas (CCAA), guiado por un panel de indicadores cualitativos y cuantitativos de la situación epidemiológica y las capacidades básicas. Las unidades territoriales evaluadas comprendían desde zonas básicas de salud hasta CCAA. Resultados: El proceso se extendió del 4 de mayo al 21 de junio y se asoció a planes de refuerzo de las capacidades en las CCAA. La incidencia disminuyó de una mediana inicial de 7,4 por 100.000 en 7 días a 2,5 al final del proceso. La mediana de pruebas PCR aumentó del 53% al 89% de los casos sospechosos, y la capacidad total de 4,5 a 9,8 pruebas semanales por 1.000 habitantes; la positividad disminuyó del 3,5% al 1,8%. La mediana de casos con contactos trazados aumentó del 82% al 100%. Conclusión: La recogida y análisis sistemático de información y el diálogo interterritorial logaron un adecuado control del proceso. La situación epidemiológica mejoró, pero sobre todo, se aumentaron las capacidades, en todo el país y con criterios comunes, cuyo mantenimiento y refuerzo fue clave en olas sucesivas.(AU)

Violencia de odio en los servicios de urgencias de hospitales de tercer nivel. Primeros datos en España / Hate violence in the emergency rooms of third level hospitals. First data in Spain

OBJETIVO: Describir los casos de violencia de odio atendidos en servicios de urgencias. MÉTODO: Estudio transversal de una serie de casos de agresión atendidos en los servicios de urgencias de dos hospitales de Madrid, entre abril de 2015 y marzo de 2018. Se describen los casos de violencia de odio en cuanto a características sociodemográficas, clínico-epidemiológicas y del incidente, y se comparan con las de otros tipos de violencia dentro del estudio. RESULTADOS: Se incluyeron 147 pacientes. El 49% refirieron haber sido víctimas de la violencia de odio. El 61% eran hombres, la media de edad fue de 36 años y un 48% tenían un nivel de estudios medio-alto. Las motivaciones más frecuentes son el aspecto físico, la nacionalidad y el origen étnico. El lugar de la agresión es la calle en un 50% de los casos, y en el 61% la agresión fue perpetrada por más de una persona (el 83% por hombres). La lesión más común fue la contusión (71%) y las localizaciones más frecuentes fueron la cabeza y el cuello (71%). El 8% de las víctimas requirieron ingreso. CONCLUSIONES: La vigilancia de la violencia de odio permitiría conocer con mayor exactitud la magnitud real y las características de este problema de salud, así como mejorar la calidad de la atención a las víctimas

OBJECTIVE: To describe the cases of hate violence attended in emergency services. METHOD: A cross-sectional study of a series of cases of aggression treated in the emergency rooms of two hospitals in Madrid, between April 2015 and March 2018. The cases of hate violence are described in terms of their sociodemographic, clinical-epidemiological and incident data and compared with other types of violence within the study. RESULTS: A total of 147 patients were included and 49% reported having been victims of hate violence. Among the victims, 61% were men, the average age was 36 years and 48% had a medium-high level of education. The most frequent motivations were physical appearance, nationality and ethnic origin. The place of aggression was the street in 50%, and in 61% of the cases it was perpetrated by more than one person (83% by men). The most common injury was contusion (71%) and the most frequent location the head and neck (71%). Only 8% required admission. CONCLUSIONS: The surveillance of hate violence would foster more accurate knowledge of the real magnitude and characteristics of this health problem and improve the quality of care for victims

Colaboración entre las revistas de salud pública en España / Collaboration between public health journals in Spain

No disponible

[Hate violence in the emergency rooms of third level hospitals. First data in Spain]. / Violencia de odio en los servicios de urgencias de hospitales de tercer nivel. Primeros datos en España.

OBJECTIVE: To describe the cases of hate violence attended in emergency services. METHOD: A cross-sectional study of a series of cases of aggression treated in the emergency rooms of two hospitals in Madrid, between April 2015 and March 2018. The cases of hate violence are described in terms of their sociodemographic, clinical-epidemiological and incident data and compared with other types of violence within the study. RESULTS: A total of 147 patients were included and 49% reported having been victims of hate violence. Among the victims, 61% were men, the average age was 36 years and 48% had a medium-high level of education. The most frequent motivations were physical appearance, nationality and ethnic origin. The place of aggression was the street in 50%, and in 61% of the cases it was perpetrated by more than one person (83% by men). The most common injury was contusion (71%) and the most frequent location the head and neck (71%). Only 8% required admission. CONCLUSIONS: The surveillance of hate violence would foster more accurate knowledge of the real magnitude and characteristics of this health problem and improve the quality of care for victims.

Coronavirus COVID-19 / No disponible

No disponible

La violencia interpersonal en España a través del Conjunto Mínimo Básico de Datos / Interpersonal violence in Spain through national hospital discharge survey

Objetivo: Describir la epidemiología de la violencia interpersonal en España. Método: Estudio descriptivo de los casos de pacientes con diagnóstico secundario de agresión registrados en el Conjunto Mínimo Básico de Datos de altas hospitalarias, entre 1999 y 2011, utilizando los códigos E960 a E969 de la Clasificación Internacional de Enfermedades (CIE-9). Se describe la distribución por sexo, edad y tipo de alta y de atención requerida, morbilidad asociada, mortalidad y comunidad autónoma. Se estudia la calidad del registro en función de su variación temporal. Resultados: El perfil de agresión en hombres (85%) es el de un paciente de entre 15 y 44 años, que en un 93,7% de los casos precisa atención urgente y cuya gravedad es moderada (95% alta a domicilio). El 2,5% de los pacientes reingresa, y se produce la muerte en el 1,1% de las ocasiones. El perfil en las mujeres (15%) difiere ligeramente: edad comprendida entre 31 y 52 años, el 94% requiere atención urgente (si bien el 96% tiene una gravedad moderada), el 3% reingresa y en el 1,7% de las ocasiones la paciente muere. Conclusiones: Aunque necesitan ser mejorados para evitar ciertas limitaciones, los sistemas de información sanitaria constituyen una riquísima fuente de datos que pueden ser utilizados para la investigación en salud y, a través de sus resultados, para el desarrollo de planes de prevención e intervención sociosanitaria en temas de violencia

Objective: To describe the epidemiology of interpersonal violence in Spain. Method: Descriptive study of the cases of patients with secondary diagnosis of aggression registered on a national hospital discharge database, between 1999 and 2011, using the codes from E960 to E969 of the ICD-9. The distribution by sex, age and type of discharge, associated morbidity, mortality and by autonomous community is described. The quality of the record is studied according to its temporal variation. Results: The case profile of aggression in men (85%) is of a patient between 15 and 44 years old, who in 93.7% of cases requires urgent care and whose severity is moderate (95% discharge home). Two point five percent of patients are readmitted and death occurs in1.1%. The profile in women (15%) differs slightly, with an age between 31 and 52 years, 94% require urgent attention, although 96% have moderate severity; 3% are readmitted and 1.7% die. Conclusions: Although they need to be improved to avoid certain limitations, health information systems are a rich source of data that can be used for research in health and, through their results, for the development of prevention plans and intervention in matters of violence

Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015.

BackgroundA large outbreak of leishmaniasis with 758 cutaneous and visceral leishmaniasis cases occurred in 2009 in Fuenlabrada, in the south-west of the Madrid region of Spain.AimWe aimed to determine the prevalence of asymptomatic Leishmania infection after this outbreak, and its associated risk factors.MethodsA cross-sectional study of 804 healthy individuals living in Fuenlabrada who had no history of leishmaniasis, was conducted between January and July 2015. Asymptomatic infections were sought by either a combination of PCR, immunofluorescent antibody titre, and direct agglutination tests, or by whole blood stimulation assay (WBA) with interleukin-2 (IL-2) quantification.ResultsUsing the first approach, prevalence of asymptomatic individuals was 1.1% (9/804), while the second returned a value of 20.7% (143/804). Older age, being male, proximity to the park where the focus of infection was identified, and living in a detached house, were all strongly associated with the prevalence of asymptomatic infection.ConclusionsThe true number of infected individuals may be underestimated if only serological methods are used. The combination of WBA with IL-2 quantification may allow to better determine the prevalence of asymptomatic Leishmania infection, which would be useful in establishing control measures and in quantifying their impact. In our study, the use of WBA with IL-2 quantification also helped establish the risk factors that influence exposure to and infection by Leishmania.

[Approach to the causes of discharge and health needs of transgender people through the National Hospital Discharge Survey in Spain during the period 2001 to 2013]. / Aproximación a las causas de ingreso de las personas trans a través del conjunto mínimo básico de datos en España durante el periodo 2001 a 2013.

OBJECTIVE: The health of transgender people is a little studied topic and hospital records can be an opportunity to make an approach. The aim of this study was to describe the cause for admission and the associated comorbidities of transgender people in Spain between 2001 and 2013. METHODS: Retrospective observational study with population-based administrative records (Minimum Basic Data Set). The discharges generated by the transgender in Spanish public and private hospitals were selected using one of the following ICD-9-CM codes in any diagnostic field: Trans-sexualism (302.5), Disorders of psychosexual identity (302.6) and Gender identity disorder in adolescents or adults (302.85). The causes of admission and comorbidity according were described. The qualitative variables were described in their frequency distribution according to their number(n) and proportion(%) and the quantitative variables according to their mean and standard deviation (SD) or median (MD) and interquartile range (RIQ) according to their distribution. RESULTS: A total of 2,010 highs were recorded corresponding to 1,878 patients. The mean age was 33 years (SD = 10). 51% were male, 46% female and 3% undetermined or unspecified. The discharges were motivated in 59% by the process of body modification, followed by HIV (4%) and personality disorders (3%). The most common comorbidities were those associated with body modification (49%), mental health problems (40%) and infectious diseases (15%). CONCLUSIONS: It is necessary to address the health of transgender people in a comprehensive way that takes into account their specific health needs, including bodily modification, mental health, HIV and other infections, through strategies that include improve research, tailor health information systems and develop guidelines and training of healthcare providers in this transgender health.

OBJETIVO: La salud de las personas transexuales es un tema poco estudiado y los registros hospitalarios pueden suponer una oportunidad para hacer una aproximación. El objetivo de este trabajo fue describir el motivo de ingreso hospitalario y las comorbilidades asociadas de las personas transexuales en España entre los años 2001 y 2013. METODOS: Estudio observacional con registros administrativos de base poblacional (Conjunto Mínimo Básico de Datos). Se seleccionaron las altas generadas de los hospitales españoles con alguno de los siguientes códigos CIE-9-MC en cualquier campo diagnóstico: Transexualismo (302.5), Trastorno de identidad sexual en niños (302.6) y Trastornos de identidad sexual en adolescentes o adultos (302.85). Se describieron las causas de ingreso y las comorbilidadades. Las variables cualitativas se describieron en su distribución de frecuencias según su número (n) y proporción (%) y las variables cuantitativas según su media y desviación estándar (DE) o mediana (MD) y rango intercuartíl (RIC) según su distribución. RESULTADOS: Se registraron 2.010 altas correspondientes a 1.878 pacientes. La edad media fue de 33 años (DE = 10). El 51% eran varones, el 46% mujeres y el 3% indeterminado. Los motivos de ingreso más frecuentes fueron los relacionados con proceso de transición (59%), seguido de VIH (4%) y trastornos de la personalidad (3%). Las comorbilidades más frecuentes estuvieron relacionadas con el proceso de transición (49%), los problemas de salud mental (40%) y las enfermedades infecciosas (15%). CONCLUSIONES: Es necesario abordar la salud de las personas trans teniendo en cuenta sus necesidades específicas de salud, entre las que se encuentran la modificación corporal, la salud mental, el VIH y otras infecciones mediante estrategias que incluyan la investigación, la adecuación de los sistemas de información sanitaria, la elaboración de guías de atención y la formación de personal de salud.

[Interpersonal violence in Spain through national hospital discharge survey]. / La violencia interpersonal en España a través del Conjunto Mínimo Básico de Datos.

OBJECTIVE: To describe the epidemiology of interpersonal violence in Spain. METHOD: Descriptive study of the cases of patients with secondary diagnosis of aggression registered on a national hospital discharge database, between 1999 and 2011, using the codes from E960 to E969 of the ICD-9. The distribution by sex, age and type of discharge, associated morbidity, mortality and by autonomous community is described. The quality of the record is studied according to its temporal variation. RESULTS: The case profile of aggression in men (85%) is of a patient between 15 and 44 years old, who in 93.7% of cases requires urgent care and whose severity is moderate (95% discharge home). Two point five percent of patients are readmitted and death occurs in1.1%. The profile in women (15%) differs slightly, with an age between 31 and 52 years, 94% require urgent attention, although 96% have moderate severity; 3% are readmitted and 1.7% die. CONCLUSIONS: Although they need to be improved to avoid certain limitations, health information systems are a rich source of data that can be used for research in health and, through their results, for the development of prevention plans and intervention in matters of violence.

Día Internacional para la Prevención del Suicidio (10 de septiembre de 2019). Trabajando juntos por su prevención / No disponible

No disponible

Día Mundial sin Tabaco (31 de mayo de 2019) / No disponible

No disponible

Semana Europea de la Vacunación (del 22 al 28 de abril de 2019) / No disponible

No disponible